Hepatitis C Treatment Has Come A Long Way
Recent reports from the United States Centers for Disease Control and Prevention (CDC) are again raising awareness of hepatitis C. A 2022 report found “too few people diagnosed with hepatitis C are being treated, despite availability of medications capable of curing this viral infection.” Specifically, the agency estimates fewer than one in three people with health insurance are getting direct-acting antiviral treatment for the infection within a year of diagnosis. A June 2023 study published by the CDC also examined gaps in access to treatment, building on the 2022 findings. The statistics resonate with Marcie Lindstrom , a gastroenterology advanced practice provider at OSF HealthCare. “If we go back 10 or 15 years, hepatitis C treatment was really difficult,” Lindstrom notes as a possible reason for the hesitancy. “Treatment lasted a year or a year and a half. It required an injection. People really felt bad during treatment.” Conversely: